The Manufacturers Life Insurance Company Sells 1,963 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

The Manufacturers Life Insurance Company lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 3.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 58,156 shares of the company’s stock after selling 1,963 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Privia Health Group were worth $1,011,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Blair William & Co. IL raised its position in shares of Privia Health Group by 125.4% in the 1st quarter. Blair William & Co. IL now owns 51,564 shares of the company’s stock valued at $1,010,000 after buying an additional 28,689 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its stake in Privia Health Group by 27.1% in the first quarter. Oppenheimer Asset Management Inc. now owns 234,991 shares of the company’s stock valued at $4,603,000 after buying an additional 50,042 shares in the last quarter. Peregrine Capital Management LLC grew its position in Privia Health Group by 11.5% in the second quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock valued at $5,461,000 after acquiring an additional 32,311 shares during the last quarter. Vanguard Group Inc. raised its stake in Privia Health Group by 2.5% during the fourth quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock worth $259,740,000 after acquiring an additional 274,345 shares in the last quarter. Finally, BlackBarn Capital Partners LP lifted its holdings in shares of Privia Health Group by 100.0% in the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after acquiring an additional 200,000 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Price Performance

Privia Health Group stock opened at $17.55 on Friday. The stock’s 50 day moving average is $18.90 and its 200 day moving average is $18.34. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35. The firm has a market cap of $2.09 billion, a P/E ratio of 117.00, a P/E/G ratio of 3.93 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm had revenue of $422.30 million during the quarter, compared to analyst estimates of $411.50 million. During the same quarter last year, the firm posted $0.06 EPS. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. Equities analysts anticipate that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PRVA has been the topic of several research reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Evercore ISI lowered their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. KeyCorp assumed coverage on Privia Health Group in a research note on Friday. They issued an “overweight” rating and a $23.00 price target for the company. Finally, Robert W. Baird upped their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Two equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $24.73.

Insider Activity

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 14.20% of the stock is owned by company insiders.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.